首页> 外国专利> VACCINE FOR THE PREVENTION OR TREATMENT OF SOME ILLNESSES WHICH RESULT FROM PATHOGEN ANSWERS, THROUGH SPECIFIC T-CELLS POPULATIONS, PREPARATION PROCESS AND DIAGNOSIS METHODS AND TREATMENT WITH THIS THEREOF

VACCINE FOR THE PREVENTION OR TREATMENT OF SOME ILLNESSES WHICH RESULT FROM PATHOGEN ANSWERS, THROUGH SPECIFIC T-CELLS POPULATIONS, PREPARATION PROCESS AND DIAGNOSIS METHODS AND TREATMENT WITH THIS THEREOF

机译:预防或治疗因病原体反应,特定T细胞人口,制备过程和诊断方法而引起的某些疾病的疫苗,并以此来治疗

摘要

The present invention provides vaccines and a means of vaccinating a mammal so as to prevent or control specific T cell mediated pathologies or to treat the unregulated replication of T cells. The vaccine is composed of a T cell receptor (TCR) or a fragment thereof corresponding to a TCR present on the surface of T cells mediating the pathology. The vaccine fragment can be a peptide corresponding to sequences of TCRs characteristic of the T cells mediating said pathology. Means of determining appropriate amino acid sequences for such vaccines are also provided. The vaccine is administered to the mammal in a manner that induces an immune response directed against the TCR of T cells mediating the pathology. This immune response down regulates or deletes the pathogenic T cells, thus ablating the disease pathogenesis. The invention additionally provides a specific beta -chain variable region of the T cell receptor, designated V beta 17, which is central to the pathogenesis of rheumatoid arthritis (RA). Also provided are means to detect, prevent and treat RA.
机译:本发明提供疫苗和给哺乳动物接种疫苗的方法,以预防或控制特定的T细胞介导的病理或治疗T细胞的复制不受调控。该疫苗由T细胞受体(TCR)或其片段组成,其对应于介导病理的T细胞表面上存在的TCR。疫苗片段可以是对应于介导所述病理的T细胞特征性TCR序列的肽。还提供了确定用于此类疫苗的合适氨基酸序列的方法。将疫苗以诱导针对介导病理的T细胞的TCR的免疫应答的方式给予哺乳动物。这种免疫反应下调或删除了致病性T细胞,从而消除了疾病的发病机理。本发明还提供了T细胞受体的特定β链可变区,称为V beta 17,其对类风湿关节炎(RA)的发病机理至关重要。还提供了检测,预防和治疗RA的手段。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号